Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
FDA Approvals
,
Payers' Guide
Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus
Read More
FDA Approvals
,
Payers' Guide
Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States
Read More
FDA Approvals
,
Payers' Guide
Competition Heats Up in Rheumatoid Arthritis and Other Autoimmune Conditions
Read More
FDA Approvals
,
Payers' Guide
Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma
Read More
Clinical Pathways and the Oncology Medical Home: First Steps to Value-Based Patient Care
Read More
Value-Based Purchasing: Implications for Hematology
Read More
Redesigning the Payment Model for Acute Leukemia: Benefits and Challenges of the Episode-of-Care Model
Read More
Measuring Value in Healthcare to Improve Quality
Read More
Multiple Myeloma
,
Oncology
Multiple Myeloma Therapy in 2015: “An Extraordinary Moment in Oncology”
Read More
Multiple Myeloma
,
Oncology
All-Oral Regimen May Become a New Standard of Care in Advanced Multiple Myeloma
Read More
114
115
116
117
118
119
120
Page 117 of 244
Results 1161 - 1170 of 2439
